Human disease models in drug development
A Loewa, JJ Feng, S Hedtrich - Nature reviews bioengineering, 2023 - nature.com
Biomedical research is undergoing a paradigm shift towards approaches centred on human
disease models owing to the notoriously high failure rates of the current drug development …
disease models owing to the notoriously high failure rates of the current drug development …
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
GE Wensink, SG Elias, J Mullenders… - NPJ precision …, 2021 - nature.com
Effective predictive biomarkers are needed to enable personalized medicine and increase
treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and …
treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and …
Applications of organoids for cancer biology and precision medicine
YH Lo, K Karlsson, CJ Kuo - Nature Cancer, 2020 - nature.com
Organoid technologies enable the creation of in vitro physiologic systems that model tissues
of origin more accurately than classical culture approaches. Seminal characteristics of these …
of origin more accurately than classical culture approaches. Seminal characteristics of these …
[HTML][HTML] Patient-derived organoids in translational oncology and drug screening
R Yang, Y Yu - Cancer Letters, 2023 - Elsevier
Patient-derived organoids (PDO) are a new biomedical research model that can reconstruct
phenotypic and genetic characteristics of the original tissue and are useful for research on …
phenotypic and genetic characteristics of the original tissue and are useful for research on …
Organoids in image-based phenotypic chemical screens
I Lukonin, M Zinner, P Liberali - Experimental & molecular medicine, 2021 - nature.com
Image-based phenotypic screening relies on the extraction of multivariate information from
cells cultured under a large variety of conditions. Technical advances in high-throughput …
cells cultured under a large variety of conditions. Technical advances in high-throughput …
DrugComb update: a more comprehensive drug sensitivity data repository and analysis portal
Combinatorial therapies that target multiple pathways have shown great promises for
treating complex diseases. DrugComb (https://drugcomb. org/) is a web-based portal for the …
treating complex diseases. DrugComb (https://drugcomb. org/) is a web-based portal for the …
Gastric organoids—an in vitro model system for the study of gastric development and road to personalized medicine
Gastric cancer ranks as the fifth most common human malignancy and the third leading
cause of cancer related deaths. Depending on tumor stage, endoscopic or surgical resection …
cause of cancer related deaths. Depending on tumor stage, endoscopic or surgical resection …
Flourishing tumor organoids: History, emerging technology, and application
Q Yang, M Li, X Yang, Z Xiao, X Tong… - Bioengineering & …, 2023 - Wiley Online Library
Malignant tumors are one of the leading causes of death which impose an increasingly
heavy burden on all countries. Therefore, the establishment of research models that closely …
heavy burden on all countries. Therefore, the establishment of research models that closely …
Enabling peristalsis of human colon tumor organoids on microfluidic chips
Peristalsis in the digestive tract is crucial to maintain physiological functions. It remains
challenging to mimic the peristaltic microenvironment in gastrointestinal organoid culture …
challenging to mimic the peristaltic microenvironment in gastrointestinal organoid culture …
The molecular mechanisms of intestinal inflammation and fibrosis in Crohn's disease
Y Hayashi, H Nakase - Frontiers in physiology, 2022 - frontiersin.org
Crohn's disease (CD) is an inflammatory bowel disease (IBD) with repeated remissions and
relapses. As the disease progresses, fibrosis and narrowing of the intestine occur, leading to …
relapses. As the disease progresses, fibrosis and narrowing of the intestine occur, leading to …